{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:25:32Z","timestamp":1790724332117,"version":"4.1.0"},"reference-count":101,"publisher":"Radcliffe Medical Media Ltd","issue":"4","license":[{"start":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T00:00:00Z","timestamp":1608768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arrhythm Electrophysiol Rev"],"abstract":"<p>Chagas disease is an important public health problem in Latin America. However, migration and globalisation have resulted in the increased presence of Chagas disease worldwide. Sudden cardiac death is the leading cause of death in people with Chagas disease, most often due to ventricular fibrillation. Although more common in patients with documented ventricular arrhythmias, sudden cardiac death can also be the first manifestation of Chagas disease in patients with no previous symptoms or known heart failure. Major predictors of sudden cardiac death include cardiac arrest, sustained and non-sustained ventricular tachycardia, left ventricular dysfunction, syncope and bradycardia. The authors review the predictors and risk stratification score developed by Rassi et al. for death in Chagas heart disease. They also discuss the evidence for anti-arrhythmic drugs, catheter ablation, ICDs and pacemakers for the prevention of sudden cardiac death in these patients. Given the widespread global burden, understanding the risk stratification and prevention of sudden cardiac death in Chagas disease is of timely concern.<\/p>","DOI":"10.15420\/aer.2020.27","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T23:39:20Z","timestamp":1610667560000},"page":"175-181","source":"Crossref","is-referenced-by-count":24,"title":["Sudden Cardiac Death Risk Stratification and Prevention in Chagas Disease: A Non-systematic Review of the Literature"],"prefix":"10.15420","volume":"9","author":[{"given":"Roberto","family":"Keegan","sequence":"first","affiliation":[{"name":"Electrophysiology Service, Hospital Privado del Sur and Hospital Espa\u00f1ol, Bahia Blanca, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Yeung","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Queen\u2019s University, Kingston, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Baranchuk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Queen\u2019s University, Kingston, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2020,12,24]]},"reference":[{"key":"ref0","unstructured":"1. WHO. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec 2015;90:33-43."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","article-title":"Pathogenesis of chronic Chagas heart disease","volume":"115","author":"Marin-Neto","year":"2007","unstructured":"2. Marin-Neto JA, Cunha-Neto E, Maciel BC, et al. Pathogenesis of chronic Chagas heart disease. Circulation 2007;115:1109-23.","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ijcard.2015.03.372","article-title":"Development of a risk score to predict sudden death in patients with Chaga's heart disease","volume":"187","author":"de Souza","year":"2015","unstructured":"3. de Souza AC, Salles G, Hasslocher-Moreno AM, et al. Development of a risk score to predict sudden death in patients with Chaga's heart disease. Int J Cardiol 2015;187:700-4.","journal-title":"Int J Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas' disease. Arq Bras Cardiol 2001;76:75-96.","DOI":"10.1590\/S0066-782X2001000100008"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ccep.2015.03.016","article-title":"Arrhythmias in chagasic cardiomyopathy","volume":"7","author":"Healy","year":"2015","unstructured":"5. Healy C, Viles-Gonzalez JF, Saenz LC, et al. Arrhythmias in chagasic cardiomyopathy. Card Electrophysiol Clin 2015;7:251-68.","journal-title":"Card Electrophysiol Clin"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Manzullo EC, Chuit R. Risk of death due to chronic chagasic cardiopathy. Mem Inst Oswaldo Cruz 1999;94(Suppl 1):317-20.","DOI":"10.1590\/S0074-02761999000700060"},{"key":"ref6","unstructured":"7. Prata A, Lopes ER, Chapadeiro E. Sudden death. In: Can\u00e7ado JR, Chuster M, eds. Chagas Disease. Belo Horizonte, Minas Gerais: Funda\u00e7\u00e3o Carlos Chagas de Pesquisa M\u00e9dica, 1985;114-20 [in Portuguese]."},{"key":"ref7","unstructured":"8. de Menezes M, Rocha A, da Silva AC, et al. Basic causes of death in elderly patients with Chagas' disease. Arquivos Brasileiros de Cardiologia 1989;52:75-8 [in Portuguese]."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1093\/eurheartj\/14.12.1610","article-title":"Clinical and morphological characteristics associated with sudden cardiac death in patients with Chagas' disease","volume":"14","author":"Bestetti","year":"1993","unstructured":"9. Bestetti RB, Freitas OC, Muccillo G, et al. Clinical and morphological characteristics associated with sudden cardiac death in patients with Chagas' disease. Eur Heart J 1993;14:1610-4.","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1540-8159.1982.tb02209.x","article-title":"Malignant ventricular arrhythmias in chronic chagasic myocarditis","volume":"5","author":"Chiale","year":"1982","unstructured":"10. Chiale PA, Halpern MS, Nau GJ, et al. Malignant ventricular arrhythmias in chronic chagasic myocarditis. Pacing Clin Electrophysiol 1982;5:162-72.","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref10","unstructured":"11. Guerrero L, Carrasco H, Parada H, et al. Ventricular mechanics and cardiac arrhythmias in patients with chagasic and primary dilated cardiomyopathy. Echo-electrocardiographic follow-up. Arq Bras Cardiol 1991;56:465-9 [in Spanish]."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1540-8167.1993.tb01247.x","article-title":"Cardiac arrhythmias in Chagas' heart disease","volume":"4","author":"MV","year":"1993","unstructured":"12. Elizari MV, Chiale PA. Cardiac arrhythmias in Chagas' heart disease. J Cardiovasc Electrophysiol 1993;4:596-608.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref12","unstructured":"13. Rassi A Jr, Rassi AG, Rassi SG, et al. Ventricular arrhythmia in Chagas disease. Diagnostic, prognostic, and therapeutic features. Arq Bras Cardiol 1995;65:377-87 [in Portuguese]."},{"key":"ref13","unstructured":"14. Barretto AC, Higuchi ML, da Luz PL, et al. Comparison of histologic changes in Chagas' cardiomyopathy and dilated cardiomyopathy. Arq Bras Cardiol 1995;52:79-83 [in Portuguese]."},{"key":"ref14","unstructured":"15. Reis Lopes E, Chapadeiro E. Pathogeny of cardiac manifestations in Chagas disease. Arq Bras Cardiol 1995;65:367-75 [in Portuguese]."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0002-9149(86)90765-4","article-title":"Sustained ventricular tachycardia in chronic chagasic myocarditis: electrophysiologic and pharmacologic characteristics","volume":"57","author":"Mendoza","year":"1986","unstructured":"16. Mendoza I, Camardo J, Moleiro F, et al. Sustained ventricular tachycardia in chronic chagasic myocarditis: electrophysiologic and pharmacologic characteristics. Am J Cardiol 1986;57:423-7.","journal-title":"Am J Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0002-9149(90)90302-H","article-title":"Angiographic and electrophysiologic substrates of ventricular tachycardia in chronic Chagasic myocarditis","volume":"65","author":"de Paola","year":"1990","unstructured":"17. de Paola AA, Horowitz LN, Miyamoto MH, et al. Angiographic and electrophysiologic substrates of ventricular tachycardia in chronic Chagasic myocarditis. Am J Cardiol 1990;65:360-3.","journal-title":"Am J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0002-9149(92)91190-F","article-title":"Ventricular tachycardia in Chagas' disease","volume":"70","author":"Giniger","year":"1992","unstructured":"18. Giniger AG, Retyk EO, Laino RA, et al. Ventricular tachycardia in Chagas' disease. Am J Cardiol 1992;70:459-62.","journal-title":"Am J Cardiol"},{"key":"ref18","unstructured":"19. Sarabanda A, Sosa E, Scanavacca M, et al. Characteristics of the induction of sustained ventricular tachycardia during programmed ventricular stimulation in chronic Chagas cadiopathy. Arq Bras Cardiol 1994;63 (Suppl I):124 [in Portuguese]."},{"key":"ref19","unstructured":"20. Rassi A, Rassi Jr A, Faria GHDC, et al. Natural history of total atrioventricular block of chagasic aetiology. Arq Bras Cardiol 1992;59 (Suppl II):191 [in Portuguese]."},{"key":"ref20","unstructured":"21. Oliveira JS, Barbieri Neto J. Chagasic cardiopathy. Rupture of the apical aneurysm. Arq Bras Cardiol 1970;23:335-8 [in Portuguese]."},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Tostes S Jr, Meneses AC, Corr\u00eaa-Araujo R, Lopes ER. Uncommon mechanisms of sudden death in chronic chagasic patients - report of 3 cases. Rev Soc Bras Med Trop 1989;22:97-8 [in Portuguese].","DOI":"10.1590\/S0037-86821989000200006"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"A Jr","year":"2010","unstructured":"23. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010;375:1388-402.","journal-title":"Lancet"},{"key":"ref23","unstructured":"24. Gonzalez J, Azzato F, Ambrosio G, et al. Sudden death is rare in the indeterminate form of Chagas disease: a systematic review. Rev Argent Cardiol 2012;80:242-9 [in Spanish]."},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Malik LH, Singh GD, Amsterdam EA. Chagas heart disease: an update. Am J Med 2015;128:1251 e7-9.","DOI":"10.1016\/j.amjmed.2015.04.036"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Nunes MCP, Beaton A, Acquatella H, et al. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association. Circulation 2018;138:e169-209.","DOI":"10.1161\/CIR.0000000000000599"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina JA","year":"2018","unstructured":"27. P\u00e9rez-Molina JA, Molina I. Chagas disease. Lancet 2018;391:82-94.","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/hrt.74.3.293","article-title":"Ventricular tachycardia during exercise testing as a predictor of sudden death in patients with chronic chagasic cardiomyopathy and ventricular arrhythmias","volume":"74","author":"de Paola","year":"1995","unstructured":"28. de Paola AA, Gomes JA, Terzian AB, et al. Ventricular tachycardia during exercise testing as a predictor of sudden death in patients with chronic chagasic cardiomyopathy and ventricular arrhythmias. Br Heart J 1995;74:293-5.","journal-title":"Br Heart J"},{"key":"ref28","unstructured":"29. Rassi SG, Rassi A Jr, Jatene JA, et al. Clinical significance of induction of ventricular fibrillation, ventricular flutter and polymorphic ventricular tachycardia sustained by electrophysiological study. Arq Bras Cardiol 1991;57:C2 [in Portuguese]."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1590\/S0066-782X2001000100008","article-title":"Sudden death in Chagas' disease","volume":"76","author":"Rassi Jr","year":"2001","unstructured":"30. Rassi Jr A, Rassi SG, Rassi A. Sudden death in Chagas' disease. Arq Bras Cardiol 2001;76:86-96.","journal-title":"Arq Bras Cardiol"},{"key":"ref30","unstructured":"31. Acquatella H, Guerra HC, Arribada A, et al. Latin American studies. In: Storino R, Milei J, eds. Chagas Disease. Buenos Aires: Mosby, Doyma; 1994;605-28 [in Spanish]."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0167-5273(94)90087-6","article-title":"Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas' disease","volume":"43","author":"Carrasco","year":"1994","unstructured":"32. Carrasco HA, Parada H, Guerrero L, et al. Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas' disease. Int J Cardiol 1994;43:27-38.","journal-title":"Int J Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1161\/01.CIR.90.6.3098","article-title":"Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy","volume":"90","author":"Mady","year":"1994","unstructured":"33. Mady C, Cardoso RH, Barretto AC, et al. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 1994;90:3098-102.","journal-title":"Circulation"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Schmidt A, Dias Romano MM, Marin-Neto JA, et al. Effects of trypanocidal treatment on echocardiographic parameters in chagas cardiomyopathy and prognostic value of wall motion score index: a BENEFIT trial echocardiographic substudy. J Am Soc Echocardiogr 2019;32:286-95 e3.","DOI":"10.1016\/j.echo.2018.09.006"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa053241","article-title":"Development and validation of a risk score for predicting death in Chagas' heart disease","volume":"355","author":"A Jr","year":"2006","unstructured":"35. Rassi A Jr, Rassi A, Little WC, et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 2006;355:799-808.","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMc062580","article-title":"A risk score for predicting death in Chagas' heart disease","volume":"355","author":"MO","year":"2006","unstructured":"36. Rocha MO, Ribeiro AL. A risk score for predicting death in Chagas' heart disease. N Engl J Med 2006;355:2488-9.","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa053241","article-title":"Development and validation of a risk score for predicting death in Chagas' heart disease","volume":"355","author":"A Jr","year":"2006","unstructured":"37. Rassi A Jr, Rassi A, Little WC, et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 2006;355:799-808.","journal-title":"N Engl J Med"},{"key":"ref37","unstructured":"38. Rassi A Jr, Waktare JEP, Rassi SG. Chagas heart disease: long term prognostic signifi-cance of nonsustained ventricular tachycardia and left ventricular dysfunction. Pacing Clin Electrophysiol 1999;22:862."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/CIRCULATIONAHA.106.627265","article-title":"Predictors of mortality in chronic Chagas disease: a sys-tematic review of observational studies","volume":"115","author":"A Jr","year":"2007","unstructured":"39. Rassi A Jr, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a sys-tematic review of observational studies. Circulation 2007;115:1101-8.","journal-title":"Circulation"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz 2009;104(Suppl 1):152-8.","DOI":"10.1590\/S0074-02762009000900021"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1016\/j.jacc.2018.08.2195","article-title":"Long-term prognostic value of myocardial fibrosis in patients with Chagas cardiomyopathy","volume":"72","author":"Senra","year":"2018","unstructured":"41. Senra T, Ianni BM, Costa ACP, et al. Long-term prognostic value of myocardial fibrosis in patients with Chagas cardiomyopathy. J Am Coll Cardiol 2018;72:2577-87.","journal-title":"J Am Coll Cardiol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.jacc.2018.09.035","article-title":"Left ventricular scar and prognosis in chronic chagas cardiomyopathy","volume":"72","author":"Volpe","year":"2018","unstructured":"42. Volpe GJ, Moreira HT, Trad HS, et al. Left ventricular scar and prognosis in chronic chagas cardiomyopathy. J Am Coll Cardiol 2018;72:2567-76.","journal-title":"J Am Coll Cardiol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jacc.2005.06.067","article-title":"Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity","volume":"46","author":"Rochitte","year":"2005","unstructured":"43. Rochitte CE, Oliveira PF, Andrade JM, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol 2005;46:1553-8.","journal-title":"J Am Coll Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"456","DOI":"10.5935\/abc.20140052","article-title":"Relationship between fibrosis and ventricular arrhythmias in Chagas heart disease without ventricular dysfunction","volume":"102","author":"Tassi","year":"2014","unstructured":"44. Tassi EM, Continentino MA, Nascimento EM, et al. Relationship between fibrosis and ventricular arrhythmias in Chagas heart disease without ventricular dysfunction. Arq Bras Cardiol 2014;102:456-64.","journal-title":"Arq Bras Cardiol"},{"key":"ref44","unstructured":"45. Rassi A, Perini GE. Propafenon in the treatment of ventricular extrasystole of Chagas disease. Controlled study unsing dynamic eletrocardiography. Arq Bras Cardiol 1979;32(Suppl 1):46 [in Portuguese]."},{"key":"ref45","unstructured":"46. Porto CC, Guimar\u00e3es E, Rosa J, Rassi A. Propafenon in the prevention of ventricular extrasystole of Chagas etiology related to physical effort. Evaluation by cycloergometry. Arq Bras Cardiol 1982;39:129-33 [in Portuguese]."},{"key":"ref46","unstructured":"47. Rassi A, Perini GE. Blind trial with disopyramide in the treatment of ventricular extrasystole in chronic chagasic heart disease controlled by the Holter system of dynamic electrocardiography. Arq Bras Cardiol 1983;41(Suppl 1):72 [in Portuguese]."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/0002-8703(84)90311-9","article-title":"Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis","volume":"107","author":"Chiale","year":"1984","unstructured":"48. Chiale PA, Halpern MS, Nau GJ, et al. Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis. Am Heart J 1984;107:656-65.","journal-title":"Am Heart J"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0167-5273(85)90238-4","article-title":"Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic pa-tients with advanced myocardial damage","volume":"9","author":"Carrasco","year":"1985","unstructured":"49. Carrasco HA, Vicuna AV, Molina C, et al. Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic pa-tients with advanced myocardial damage. Int J Cardiol 1985;9:425-38.","journal-title":"Int J Cardiol"},{"key":"ref49","unstructured":"50. Rassi A Jr, Rassi AG, Rassi SG, et al. Amiodarone in the treatment of ventricular extrasystole of chronic chagasic heart disease, with dosage adjustments controlled by Holter and exercise test. Arq Bras Cardiol 1991;57(Suppl C):8 [in Portuguese]."},{"key":"ref50","unstructured":"51. Gizzi JC, Moreira DR, Sierra C, et al. Antiarrhythmic action of sotalol in cardiac patients with complex ventricular arrhythmia. Arq Bras Cardiol 1994;63(Suppl I):71 [in Portuguese]."},{"key":"ref51","unstructured":"52. Rassi A Jr, Rassi AG, Rassi SG, et al. Effects of increasing doses of amiodarone on the suppression of ventricular arrhythmia with Holter and exercise testing in chronic Chagas heart disease. Arq Bras Cardiol 1994;63(Suppl I):123 [in Portuguese]."},{"key":"ref52","unstructured":"53. Rassi A, Rassi A Jr, Perini GE, et al. Efficacy of different antiarrhythmic drugs in suppressing ventricular arrhythmia in chronic Chagas disease. Analysis using dynamic electrocardiography. Arq Bras Cardiol 1996;67(Suppl I):38 [in Portuguese]."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","unstructured":"54. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-8.","journal-title":"N Engl J Med"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1056\/NEJM199207233270403","article-title":"Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction","volume":"327","author":"II Investigators","year":"1992","unstructured":"55. CAST II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-33.","journal-title":"N Engl J Med"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"56. Stein C, Migliavaca CB, Colpani V, et al. Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis. PLoS Negl Trop Dis 2018;12:e0006742.","DOI":"10.1371\/journal.pntd.0006742"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/0735-1097(90)90324-I","article-title":"Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)","volume":"16","author":"Burkart","year":"1990","unstructured":"57. Burkart F, Pfisterer M, Kiowski W, et al. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol 1990;16:1711-8.","journal-title":"J Am Coll Cardiol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/0735-1097(92)90357-S","article-title":"Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study","volume":"20","author":"Ceremuzynski","year":"1992","unstructured":"58. Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, et al. Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol 1992;20:1056-62.","journal-title":"J Am Coll Cardiol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/0002-9149(93)90291-J","article-title":"Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction","volume":"72","author":"Navarro-Lopez","year":"1993","unstructured":"59. Navarro-Lopez F, Cosin J, Marrugat J, et al. Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. Am J Cardiol 1993;72:1243-8.","journal-title":"Am J Cardiol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(94)91895-3","article-title":"Randomised trial of low-dose amiodarone in severe congestive heart failure","volume":"344","author":"Doval","year":"1994","unstructured":"60. Doval HC, Nul DR, Grancelli HO, et al. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994;344:493-8.","journal-title":"Lancet"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/0002-8703(95)90357-7","article-title":"Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA)","volume":"130","author":"Garguichevich","year":"1995","unstructured":"61. Garguichevich JJ, Ramos JL, Gambarte A, et al. Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA). Am Heart J 1995;130:494-500.","journal-title":"Am Heart J"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(97)05281-1","article-title":"Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials","volume":"350","author":"ATM-A Investigators","year":"1997","unstructured":"62. ATM-A Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417-24.","journal-title":"Lancet"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0140-6736(96)08171-8","article-title":"Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT","volume":"349","author":"Cairns","year":"1997","unstructured":"63. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997;349:675-82.","journal-title":"Lancet"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1161\/01.CIR.96.9.2823","article-title":"Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death","volume":"96","author":"Sim","year":"1997","unstructured":"64. Sim I, McDonald KM, Lavori PW, et al. Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death. Circulation 1997;96:2823-9.","journal-title":"Circulation"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1046\/j.1540-8167.2003.02278.x","article-title":"Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol","volume":"14","author":"Leite","year":"2003","unstructured":"65. Leite LR, Fenelon G, Simoes A Jr, et al. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol. J Cardiovasc Electrophysiol 2003;14:567-73.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/CIRCHEARTFAILURE.109.882035","article-title":"Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial","volume":"3","author":"Issa","year":"2010","unstructured":"66. Issa VS, Amaral AF, Cruz FD, et al. Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial. Circ Heart Fail 2010;3:82-8.","journal-title":"Circ Heart Fail"},{"key":"ref66","unstructured":"67. Takehara K, Scanavacca M, Sosa E, et al. Anatomo-pathological aspects of the focus of recurrent sustained ventricular tachycardia of chronic chagasic cardiomyopathy. Arq Bras Cardiol 55(Suppl B):68 [in Portuguese]."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"524","DOI":"10.5935\/abc.20140082","article-title":"Epicardial ablation for ventricular tachycardia in chronic Chagas heart disease","volume":"102","author":"Scanavacca","year":"2014","unstructured":"68. Scanavacca M. Epicardial ablation for ventricular tachycardia in chronic Chagas heart disease. Arq Bras Cardiol 2014;102:524-8.","journal-title":"Arq Bras Cardiol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/europace\/euu322","article-title":"The first Latin American Catheter Ablation Registry","volume":"17","author":"Keegan","year":"2015","unstructured":"69. Keegan R, Aguinaga L, Fenelon G, et al. The first Latin American Catheter Ablation Registry. Europace 2015;17:794-800.","journal-title":"Europace"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10840-009-9433-4","article-title":"Simultaneous epicardial and endocardial substrate mapping and radiofrequency catheter ablation as first-line treatment for ventricular tachycardia and frequent ICD shocks in chronic chagasic cardiomyopathy","volume":"26","author":"Henz","year":"2009","unstructured":"70. Henz BD, do Nascimento TA, de Oliveira Dietrich C, et al. Simultaneous epicardial and endocardial substrate mapping and radiofrequency catheter ablation as first-line treatment for ventricular tachycardia and frequent ICD shocks in chronic chagasic cardiomyopathy. J Interv Card Electrophysiol 2009;26:195-205.","journal-title":"J Interv Card Electrophysiol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.hrthm.2020.02.009","article-title":"Efficacy and safety of combined endocardial\/epicardial catheter ablation for ventricular tachycardia in Chagas disease: a randomized controlled study","volume":"17","author":"Pisani","year":"2020","unstructured":"71. Pisani CF, Romero J, Lara S, et al. Efficacy and safety of combined endocardial\/epicardial catheter ablation for ventricular tachycardia in Chagas disease: a randomized controlled study. Heart Rhythm 2020;17:1510-8.","journal-title":"Heart Rhythm"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia","volume":"335","author":"Moss","year":"1996","unstructured":"72. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.","journal-title":"N Engl J Med"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A comparison of antiarrhythmic-drug therapy with implantable defib-rillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","author":"Investigators","year":"1997","unstructured":"73. AVID Investigators. A comparison of antiarrhythmic-drug therapy with implantable defib-rillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.","journal-title":"N Engl J Med"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","unstructured":"74. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.","journal-title":"N Engl J Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","unstructured":"75. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302.","journal-title":"Circulation"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","unstructured":"76. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54.","journal-title":"Circulation"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","unstructured":"77. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.","journal-title":"N Engl J Med"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","unstructured":"78. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-8.","journal-title":"N Engl J Med"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","unstructured":"79. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.","journal-title":"N Engl J Med"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"80. da Matta JA, Aras R Jr, de Macedo CR, et al. Stroke correlates in chagasic and non-chagasic cardiomyopathies. PLoS One 2012;7:e35116.","DOI":"10.1371\/journal.pone.0035116"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.gheart.2015.07.006","article-title":"Prevalence and risk factors of embolic cerebrovascular events associated with Chagas heart disease","volume":"10","author":"Nunes","year":"2015","unstructured":"81. Nunes MC, Kreuser LJ, Ribeiro AL, et al. Prevalence and risk factors of embolic cerebrovascular events associated with Chagas heart disease. Glob Heart 2015;10:151-7.","journal-title":"Glob Heart"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.amjcard.2014.02.036","article-title":"Relation of interatrial block to new-onset atrial fibrillation in patients with Chagas cardiomyopathy and implantable cardioverter-defibrillators","volume":"113","author":"Enriquez","year":"2014","unstructured":"82. Enriquez A, Conde D, Femenia F, et al. Relation of interatrial block to new-onset atrial fibrillation in patients with Chagas cardiomyopathy and implantable cardioverter-defibrillators. Am J Cardiol 2014;113:1740-3.","journal-title":"Am J Cardiol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/01.STR.0000163104.92943.50","article-title":"Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease","volume":"36","author":"Carod-Artal","year":"2005","unstructured":"83. Carod-Artal FJ, Vargas AP, Horan TA, et al. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke 2005;36:965-70.","journal-title":"Stroke"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1161\/STROKEAHA.109.560854","article-title":"Chagas disease: independent risk factor for stroke","volume":"40","author":"Paixao","year":"2009","unstructured":"84. Paixao LC, Ribeiro AL, Valacio RA, et al. Chagas disease: independent risk factor for stroke. Stroke 2009;40:3691-4.","journal-title":"Stroke"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijcard.2018.05.091","article-title":"Implantable cardioverter-defibrillator in Chagas heart disease: A systematic review and meta-analysis of observational studies","volume":"267","author":"Carmo","year":"2018","unstructured":"85. Carmo AAL, de Sousa MR, Agudelo JF, et al. Implantable cardioverter-defibrillator in Chagas heart disease: A systematic review and meta-analysis of observational studies. Int J Cardiol 2018;267:88-93.","journal-title":"Int J Cardiol"},{"key":"ref85","unstructured":"86. Scanavacca MI, Sosa EA, Lee JH, et al. Empiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardia. Arq Bras Cadiol 1990;54:367-71 [in Portugese]."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1540-8167.2007.00954.x","article-title":"Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy","volume":"18","author":"Cardinalli-Neto","year":"2007","unstructured":"87. Cardinalli-Neto A, Bestetti RB, Cordeiro JA, et al. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy. J Cardiovasc Elecrophysiol 2007;18:1236-40.","journal-title":"J Cardiovasc Elecrophysiol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/europace\/eun325","article-title":"Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America","volume":"11","author":"Muratore","year":"2009","unstructured":"88. Muratore CA, Batista Sa LA, Chiale PA, et al. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America. Europace 2009;11:164-8.","journal-title":"Europace"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1540-8159.2010.02896.x","article-title":"Predictors of mortality in patients with Chagas' cardiomyopathy and ventricular tachycardia not treated with implantable cardioverter-defibrillators","volume":"34","author":"Sarabanda","year":"2011","unstructured":"89. Sarabanda AV, Marin-Neto JA. Predictors of mortality in patients with Chagas' cardiomyopathy and ventricular tachycardia not treated with implantable cardioverter-defibrillators. Pacing Clin Electrophysiol 2011;34:54-62.","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.amjcard.2012.05.040","article-title":"Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in Chagas' heart disease","volume":"110","author":"Martinelli","year":"2012","unstructured":"90. Martinelli M, de Siqueira SF, Sternick EB, et al. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in Chagas' heart disease. Am J Cardiol 2012;110:1040-5.","journal-title":"Am J Cardiol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/europace\/eut011","article-title":"Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease","volume":"15","author":"Barbosa","year":"2013","unstructured":"91. Barbosa MP, da Costa Rocha MO, de Oliveira AB, et al. Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease. Europace 2013;15:957-62.","journal-title":"Europace"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/europace\/euz012","article-title":"Predictors of mortality and heart transplantation in patients with Chagas' cardiomyopathy and ventricular tachycardia treated with implantable cardioverter-defibrillators","volume":"21","author":"Gali","year":"2019","unstructured":"92. Gali WL, Sarabanda AV, Baggio JM, et al. Predictors of mortality and heart transplantation in patients with Chagas' cardiomyopathy and ventricular tachycardia treated with implantable cardioverter-defibrillators. Europace 2019;21:1070-78.","journal-title":"Europace"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.jacep.2019.07.003","article-title":"Systematic review and meta-analysis of clinical outcome after implantable cardioverter-defibrillator therapy in patients with Chagas heart disease","volume":"5","author":"Rassi","year":"2019","unstructured":"93. Rassi FM, Minohara L, Rassi A Jr, et al. Systematic review and meta-analysis of clinical outcome after implantable cardioverter-defibrillator therapy in patients with Chagas heart disease. JACC Clin Electrophysiol 2019;5:1213-23.","journal-title":"JACC Clin Electrophysiol"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1540-8159.2011.03108.x","article-title":"Predictors of all-cause 1-year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy","volume":"34","author":"di Toro","year":"2011","unstructured":"94. di Toro D, Muratore C, Aguinaga L, et al. Predictors of all-cause 1-year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy. Pacing Clin Electrophysiol 2011;34:1063-9.","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/pace.13333","article-title":"Long-term follow-up of Chagas heart disease patients receiving an implantable cardioverter-defibrillator for secondary prevention","volume":"41","author":"Pavao","year":"2018","unstructured":"95. Pavao M, Arfelli E, Scorzoni-Filho A, et al. Long-term follow-up of Chagas heart disease patients receiving an implantable cardioverter-defibrillator for secondary prevention. Pacing Clin Electrophysiol 2018;41:583-8.","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref95","unstructured":"96. Mitelman J, Descalzo A, Gimenez L, et al. Consensus statement on Chagas-Mazza disease. Rev Argent Cardiol 2011;79:544-64."},{"key":"ref96","unstructured":"97. Andrade JP, Marin Neto JA, Paola AA, et al. I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol 2011;96:434-42 [in Portugese, Spanish]."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/europace\/eut123","article-title":"ICDs in Chagas heart disease: the standard treatment for secondary prevention of sudden death","volume":"15","author":"Barbosa","year":"2013","unstructured":"98. Barbosa MP, Rocha MO, Lombardi F, et al. ICDs in Chagas heart disease: the standard treatment for secondary prevention of sudden death. Europace 2013;15:1383-4.","journal-title":"Europace"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1590\/0037-8682-0003-2014","article-title":"Ventricular arrhythmias in Chagas disease","volume":"48","author":"Barbosa","year":"2015","unstructured":"99. Barbosa MP, Carmo AA, Rocha MO, et al. Ventricular arrhythmias in Chagas disease. Rev Soc Bras Med Trop 2015;48:4-10.","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"100. Martinelli M, Rassi A, Jr, Marin-Neto JA, et al. CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy Study: rationale and design of a randomized clinical trial. Am Heart J 2013;166:976-82.e4.","DOI":"10.1016\/j.ahj.2013.08.027"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ijcard.2017.10.031","article-title":"Predictors of death in chronic Chagas cardiomyopathy patients with pacemaker","volume":"250","author":"Peixoto","year":"2018","unstructured":"101. Peixoto GL, Martinelli Filho M, Siqueira SF, et al. Predictors of death in chronic Chagas cardiomyopathy patients with pacemaker. Int J Cardiol 2018;250:260-5.","journal-title":"Int J Cardiol"}],"container-title":["Arrhythmia &amp; Electrophysiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aerjournal.com\/articles\/sudden-cardiac-death-risk-stratification","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:46:06Z","timestamp":1783615566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerjournal.com\/articleindex\/aer.2020.27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,24]]},"references-count":101,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12,24]]}},"alternative-id":["aer.2020.27"],"URL":"https:\/\/doi.org\/10.15420\/aer.2020.27","relation":{},"ISSN":["2050-3369","2050-3377"],"issn-type":[{"value":"2050-3369","type":"print"},{"value":"2050-3377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,24]]}}}